InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,446.68
(
-1.37%
)
US TECH 100
18,106.40
(
-1.52%
)
Dow Jones
40,347.97
(
-1.21%
)
Brent Oil
79.54
(
-0.54%
)
Bitcoin
64,777.06
(
-0.88%
)
Post# of 252775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120193
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 113545

Friday, 01/28/2011 11:05:25 AM

Friday, January 28, 2011 11:05:25 AM

Post# of 252775

… the recent bad news on Iniparib is pretty ironic given they just published their very successful Ph II in the NEJM

We haven’t talked about program-survival bias on this board lately, but the concept remains as germane to biotech investing as ever.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up